Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Moat Score: 0/10 (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603707 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd SHSE:603707
65 GF Score
Price ¥7.55
GF Value ¥12.70
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Nanjing King-Friend Biochemical Pharmaceutical Co Moat Score?

Nanjing King-Friend Biochemical Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Nanjing King-Friend Biochemical Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Nanjing King-Friend Biochemical Pharmaceutical Co might have No Moat - No discernible moat.

Nanjing King-Friend Biochemical Pharmaceutical Co  (SHSE:603707) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Nanjing King-Friend Biochemical Pharmaceutical Co Moat Score Related Terms

SHSE:603707
65GF Score
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd SHSE:603707
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing King-Friend Biochemical Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥7.55 is trading 40.6% below its estimated GF Value™ of ¥12.70. GuruFocus considers Nanjing King-Friend Biochemical Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603707:

  • Moat Score: 0
  • GF Value™: ¥12.70 vs. price of ¥7.55 (40.6% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanjing King-Friend Biochemical Pharmaceutical Co Business Description

Address 1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.
65GF Score

Get the complete analysis for SHSE:603707

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.55
Price
¥12.70
GF Value